Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
G MatejkaJ M Brun

Abstract

Graves' ophthalmopathy (GO) is a specific immune-mediated disorder, whose treatment is sometimes difficult. In order to investigate the efficacy of intravenous methylprednisolone (MP) pulse therapy in GO, we studied eight patients with GO, followed up for at least 6 months by clinical patient self-assessment, ophthalmological examination and orbital computed tomography (OCT). A 12.5 mg/kg dose of MP was administered intravenously over a 10 hour period, once every month. Three to six MP pulse administrations were performed in each patient. All patients were outpatients. A 0.5 mg/kg/day oral prednisone dose was given to each patient as interpulse therapy. Clinical assessment of MP pulse therapy showed a good response in 87.5% and no response in 12.5% of patients. The treatment was rapidly efficient, mostly on patient self-assessment, soft tissue inflammation, ophthalmoplegia, corneal involvement, visual acuity and extraocular muscle enlargement on OCT. Post-treatment ophthalmic index was significantly improved (6.75 +/- 3.06 vs. 2.5 +/- 1.41: p < 0.05). MP pulse therapy had less effect on proptosis (22.94 +/- 2.32 mm vs. 21.56 +/- 2.22 mm: p < 0.05). No adverse effects were noted with MP pulse therapy. Patients showed no relapse ...Continue Reading

Citations

Mar 5, 2003·American Journal of Ophthalmology·Kenji OhtsukaYasuo Suzuki
Aug 7, 2002·Trends in Endocrinology and Metabolism : TEM·Wilmar M Wiersinga, Mark F Prummel
Feb 1, 2007·Seminars in Plastic Surgery·Adel H Alsuhaibani, Jeffrey A Nerad
Apr 16, 2002·Thyroid : Official Journal of the American Thyroid Association·Petros Perros, Pat Kendall-Taylor
Aug 24, 2004·Thyroid : Official Journal of the American Thyroid Association·Mario SalviPaolo Beck-Peccoz
Aug 25, 2005·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Richard H HartPetros Perros
Jan 25, 2002·The British Journal of Ophthalmology·Alan A McNab
Jan 15, 2014·Thyroid : Official Journal of the American Thyroid Association·Nicola CurròMario Salvi
Feb 11, 2012·Journal of Endocrinological Investigation·S ZangG J Kahaly
Nov 16, 2011·Aesthetic Plastic Surgery·Daniel J GouldCharles N S Soparkar
Jul 20, 2010·Neurologic Clinics·Kimberly P Cockerham, Stephanie S Chan
Aug 16, 2000·Dermatologic Clinics·S Sabir, V P Werth
Apr 2, 2016·European Journal of Endocrinology·Irene CampiMario Salvi
Jan 1, 2005·Current Opinion in Ophthalmology·Patrick Roland Boulos, Isabelle Hardy
Sep 19, 2006·Drugs·Sara P ModjtahediIgal Leibovitch
Sep 27, 2007·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Christopher I ZoumalanSteven E Feldon
Aug 12, 2014·Orvosi hetilap·Annamária ErdeiV Endre Nagy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.